Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PUFA in Adolescents with Anorexia Nervosa
DRKS00017130Phase 2Completed
- Sponsor
- Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters
- Start
- Nov 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of docosahexaenoic acid, eicosapentaenoic acid and vitamin d in anorexia nervosa (AN) (2 arms), sponsored by Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters. Primary endpoint: Change in gut microbiome composition. Started Nov 2019; status: completed.
02
Drugs
docosahexaenoic acideicosapentaenoic acidvitamin d
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on DRKS00017130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00017130.